Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 92 articles:
HTML format
Text format



Single Articles


    November 2017
  1. DIETZ J, Susser S, Vermehren J, Peiffer KH, et al
    Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 13. pii: S0016-5085(17)36353.
    PubMed     Text format     Abstract available


  2. DEBES JD, van Tilborg M, Groothuismink ZMA, Hansen BE, et al
    Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36295.
    PubMed     Text format     Abstract available


    October 2017
  3. RATTAY T, Dumont P, Heinzow HS, Hutton DW, et al
    Cost-effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.
    Gastroenterology. 2017 Oct 23. pii: S0016-5085(17)36275.
    PubMed     Text format     Abstract available


  4. JOHN M, Metwally M, Mangia A, Romero-Gomez M, et al
    TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.
    Gastroenterology. 2017 Oct 6. pii: S0016-5085(17)36134.
    PubMed     Text format    


  5. MONDELLI MU
    Liver MAIT Cells in Hepatitis C: Pathogenetic Role or Innocent Bystanders?
    Gastroenterology. 2017 Oct 4. pii: S0016-5085(17)36186.
    PubMed     Text format    


    September 2017
  6. MONTPELLIER C, Wychowski C, Sayed IM, Meunier JC, et al
    Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.
    Gastroenterology. 2017 Sep 25. pii: S0016-5085(17)36179.
    PubMed     Text format     Abstract available


  7. CHILDS-KEAN LM, Hong J
    Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)35912.
    PubMed     Text format    


    August 2017
  8. MAAN R, Feld JJ
    Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
    Gastroenterology. 2017 Aug 31. pii: S0016-5085(17)36085.
    PubMed     Text format    


  9. YU ML
    Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C.
    Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35886.
    PubMed     Text format    


  10. BOLTE FJ, O'Keefe AC, Webb LM, Serti E, et al
    Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35975.
    PubMed     Text format     Abstract available


    July 2017
  11. MISHRA P, Florian J, Peter J, Vainorius M, et al
    Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35956.
    PubMed     Text format    


  12. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Text format     Abstract available


  13. YU MW, Lin CL, Liu CJ, Yang SH, et al
    Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.
    Gastroenterology. 2017 Jul 12. pii: S0016-5085(17)35866.
    PubMed     Text format     Abstract available


    June 2017
  14. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Text format     Abstract available


  15. ENOMOTO M, Murakami Y, Kawada N
    Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35638.
    PubMed     Text format    


  16. DE MARCO L, Pellicano R
    When to Search for Occult Infection After Eradication of Hepatitis C?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35601.
    PubMed     Text format    


    May 2017
  17. KANWAL F, Bacon BR, Beste LA, Brill JV, et al
    Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group.
    Gastroenterology. 2017;152:1588-1598.
    PubMed     Text format    


  18. SINGH S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology. 2017;152:1544-1577.
    PubMed     Text format     Abstract available


    April 2017
  19. LAIDLAW SM, Marukian S, Gilmore RH, Cashman SB, et al
    Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent from Interferons.
    Gastroenterology. 2017 Apr 26. pii: S0016-5085(17)35530.
    PubMed     Text format     Abstract available


  20. JACOBSON IM, Lawitz E, Gane EJ, Willems BE, et al
    Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir In Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
    Gastroenterology. 2017 Apr 5. pii: S0016-5085(17)35399.
    PubMed     Text format     Abstract available


    March 2017
  21. JACOBSON IM, Lim JK, Fried MW
    AGA Institute Clinical Practice Update: Care of Patients Who Have Achieved a Sustained Virologic Response (SVR) Following Antiviral Therapy for Chronic Hepatitis C Infection.
    Gastroenterology. 2017 Mar 23. pii: S0016-5085(17)30327.
    PubMed     Text format     Abstract available


  22. MISHRA P, Chen M
    Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?
    Gastroenterology. 2017 Mar 18. pii: S0016-5085(17)30295.
    PubMed     Text format    


  23. SAADOUN D, Pol S, Ferfar Y, Alric L, et al
    Efficacy and Safety of Sofosbuvir plus Daclatasvir for Treatment of HCV-associated Cryoglobulinemia Vasculitis.
    Gastroenterology. 2017 Mar 10. pii: S0016-5085(17)30269.
    PubMed     Text format     Abstract available


  24. COMARMOND C, Garrido M, Pol S, Desbois AC, et al
    Direct-acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-induced Cryoglobulinemia Vasculitis.
    Gastroenterology. 2017 Mar 5. pii: S0016-5085(17)30235.
    PubMed     Text format     Abstract available


  25. LIAW YF, Chu CM
    Immune Tolerance Phase of Chronic Hepatitis B.
    Gastroenterology. 2017 Mar 5. pii: S0016-5085(17)30137.
    PubMed     Text format    


  26. SINGAL AK, Shah VH, Kamath PS
    Infection in Severe Alcoholic Hepatitis: Yet Another Piece in the Puzzle.
    Gastroenterology. 2017 Mar 1. pii: S0016-5085(17)30217.
    PubMed     Text format    


    February 2017
  27. KLIGMAN E, Kwo PY
    Confirming What We Believed: Reducing and Eliminating Vertical Transmission of Hepatitis B.
    Gastroenterology. 2017 Feb 28. pii: S0016-5085(17)30206.
    PubMed     Text format    


  28. AGHEMO A, Colombo M
    Response-Guided Duration of Directly Acting Antiviral Therapy for Chronic Hepatitis C: Back to the Future?
    Gastroenterology. 2017 Feb 27. pii: S0016-5085(17)30205.
    PubMed     Text format    


  29. LOOMBA R, Liang TJ
    Hepatitis B reactivation associated with immune suppressive and biological modifier therapies: current concepts, management strategies and future directions.
    Gastroenterology. 2017 Feb 17. pii: S0016-5085(17)30173.
    PubMed     Text format     Abstract available


  30. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


  31. MATSUURA K, Sawai H, Ikeo K, Ogawa S, et al
    Genome-wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Gastroenterology. 2017 Feb 2. pii: S0016-5085(17)30130.
    PubMed     Text format     Abstract available


  32. RAVI S, Axley P, Jones D, Kodali S, et al
    Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Gastroenterology. 2017 Feb 1. pii: S0016-5085(16)35535.
    PubMed     Text format    


    January 2017
  33. GANE EJ, Hyland RH, Yang Y, Svarovskaia E, et al
    Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.
    Gastroenterology. 2017 Jan 27. pii: S0016-5085(17)30074.
    PubMed     Text format     Abstract available


  34. GOLDBERG D, Ditah IC, Saeian K, Lalehzari M, et al
    Changes in the Prevalence of Hepatitis C Virus Infection, Non-alcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
    Gastroenterology. 2017 Jan 11. pii: S0016-5085(17)30014.
    PubMed     Text format     Abstract available


  35. BESSE-PATIN A, Leveille M, Oropeza D, Nguyen BN, et al
    Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1alpha to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
    Gastroenterology. 2017;152:243-256.
    PubMed     Text format     Abstract available


    December 2016
  36. VERGIS N, Atkinson SR, Knapp S, Maurice J, et al
    Patients With Severe Alcoholic Hepatitis Given Prednisolone Therapy Who Have High Circulating Levels Of Bacterial DNA are at Increased Risk for Developing Infections.
    Gastroenterology. 2016 Dec 30. pii: S0016-5085(16)35533.
    PubMed     Text format     Abstract available


  37. KOUTSOUDAKIS G, Perez-Del-Pulgar S, Forns X
    Occult Hepatitis C Virus Infection: Are We Digging Too Deep?
    Gastroenterology. 2016 Dec 27. pii: S0016-5085(16)35528.
    PubMed     Text format    


  38. BOSON B, Denolly S, Turlure F, Chamot C, et al
    Daclatasvir Prevents Hepatitis C Virus by Blocking Transfer of Viral Genome to Assembly Sites.
    Gastroenterology. 2016 Dec 5. pii: S0016-5085(16)35447.
    PubMed     Text format     Abstract available


    November 2016
  39. COLPITTS CC, Baumert TF
    SMAD about HCV cell entry and pathogenesis of liver disease.
    Gastroenterology. 2016 Nov 23. pii: S0016-5085(16)35398.
    PubMed     Text format    


  40. DONNELLY MC, Imlach SN, Abravanel F, Ramalingam S, et al
    Sofosbuvir and Daclatasvir Anti-Viral Therapy Fails to Clear HEV Viremia and Restore Reactive T Cells in a HEV/HCV Co-Infected Liver Transplant Recipient.
    Gastroenterology. 2016 Nov 21. pii: S0016-5085(16)34895.
    PubMed     Text format    


  41. ELMASRY S, Wadhwa S, Bang BR, Cook L, et al
    Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-acting Antiviral Agents for Recurrent Infection After Liver Transplantation.
    Gastroenterology. 2016 Nov 9. pii: S0016-5085(16)35323.
    PubMed     Text format     Abstract available


  42. WANG W, Hakim MS, Nair VP, de Ruiter PE, et al
    Distinct Antiviral Potency of Sofosbuvir against Hepatitis C and E Viruses.
    Gastroenterology. 2016 Nov 1. pii: S0016-5085(16)35194.
    PubMed     Text format    


    October 2016
  43. KOMATSU TE, Boyd S, Sherwat A, Tracy L, et al
    Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir.
    Gastroenterology. 2016 Oct 20. pii: S0016-5085(16)35241.
    PubMed     Text format     Abstract available


  44. LIANG TJ
    Hepatitis C Virus: from Obscurity to the Lasker.
    Gastroenterology. 2016 Oct 17. pii: S0016-5085(16)35233.
    PubMed     Text format    


  45. KWO P, Gane E, Peng CY, Pearlman B, et al
    Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients with Chronic Hepatitis C Infection.
    Gastroenterology. 2016 Oct 5. pii: S0016-5085(16)35170.
    PubMed     Text format     Abstract available


  46. AGHEMO A, Buti M
    Hepatitis C Therapy: Game Over!
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35131.
    PubMed     Text format    


  47. PROTZER U, Knolle P
    "To Be or Not to Be": Immune Tolerance in Chronic Hepatitis B.
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35135.
    PubMed     Text format    


  48. MILICH DR
    The Concept of Immune Tolerance in Chronic Hepatitis B Virus Infection Is Alive and Well.
    Gastroenterology. 2016 Oct 1. pii: S0016-5085(16)35134.
    PubMed     Text format    


    September 2016
  49. ZHANG F, Sodroski C, Cha H, Li Q, et al
    Infection of Hepatocytes with HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Upregulating SMAD6 and SMAD7.
    Gastroenterology. 2016 Sep 29. pii: S0016-5085(16)35128.
    PubMed     Text format     Abstract available


  50. NAHON P, Bourcier V, Layese R, Audureau E, et al
    Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
    Gastroenterology. 2016 Sep 15. pii: S0016-5085(16)35070.
    PubMed     Text format     Abstract available


    August 2016
  51. PAWLOTSKY JM
    Hepatitis C Drugs: Is Next Generation the Last Generation?
    Gastroenterology. 2016 Aug 30. pii: S0016-5085(16)34985.
    PubMed     Text format    


  52. TERRAULT NA, Zeuzem S, Di Bisceglie AM, Lim JK, et al
    Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated of Sustained Virologic Response.
    Gastroenterology. 2016 Aug 23. pii: S0016-5085(16)34927.
    PubMed     Text format     Abstract available


  53. SETH A, Alexander JS, Jordan PA
    A Rare Cause of Hepatitis: "Think Outta the Box!"
    Gastroenterology. 2016 Aug 1. pii: S0016-5085(16)34435.
    PubMed     Text format    


    July 2016
  54. LAWITZ E, Reau N, Hinestrosa F, Rabinovitz M, et al
    Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients with Genotype 1 Hepatitis C Virus Infection in an Open-label, Phase 2 Trial.
    Gastroenterology. 2016 Jul 30. pii: S0016-5085(16)34835.
    PubMed     Text format     Abstract available


  55. GANE E, Kowdley KV, Pound D, Stedman CA, et al
    Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients with HCV Genotype 2, 3, 4, or 6 Infections in an Open-label, Phase 2 Trial.
    Gastroenterology. 2016 Jul 30. pii: S0016-5085(16)34834.
    PubMed     Text format     Abstract available


  56. AFDHAL NH, Serfaty L
    Cohort Studies and Registries in the treatment of HCV; the impact of "real life" effectiveness.
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34820.
    PubMed     Text format    


  57. SHERMAN M
    Hepatitis B vaccination: Putting hepatologists out of business?
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34819.
    PubMed     Text format    


  58. GANE E, Poordad F, Wang S, Asatryan A, et al
    High Efficacy of ABT-493 and ABT-530 in Patients with HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.
    Gastroenterology. 2016 Jul 22. pii: S0016-5085(16)34816.
    PubMed     Text format     Abstract available


  59. MASON WS, Gill US, Litwin S, Zhou Y, et al
    HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.
    Gastroenterology. 2016 Jul 21. pii: S0016-5085(16)34808.
    PubMed     Text format     Abstract available


  60. RAMIREZ S, Mikkelsen LS, Gottwein JM, Bukh J, et al
    Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir.
    Gastroenterology. 2016 Jul 21. pii: S0016-5085(16)34809.
    PubMed     Text format     Abstract available


  61. SHIN JY, Azoulay L, Filion KB
    Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?
    Gastroenterology. 2016 Jul 1. pii: S0016-5085(16)34434.
    PubMed     Text format    


    June 2016
  62. GAMBATO M, Perez-Del-Pulgar S, Hedskog C, Svarovskia ES, et al
    HCV RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.
    Gastroenterology. 2016 Jun 30. pii: S0016-5085(16)34697.
    PubMed     Text format     Abstract available


  63. SARRAZIN C, Dvory-Sobol H, Svarovskaia ES, Doehle B, et al
    Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment with Ledipasvir and Sofosbuvir.
    Gastroenterology. 2016 Jun 10. pii: S0016-5085(16)34614.
    PubMed     Text format     Abstract available


  64. IOANNOU GN, Beste LA, Chang MF, Green PK, et al
    Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Healthcare System.
    Gastroenterology. 2016 Jun 4. pii: S0016-5085(16)34575.
    PubMed     Text format     Abstract available


  65. CHANG MH, You SL, Chen CJ, Liu CJ, et al
    Long-Term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.
    Gastroenterology. 2016 Jun 3. pii: S0016-5085(16)34574.
    PubMed     Text format     Abstract available


    May 2016
  66. GANE EJ, Schwabe C, Hyland RH, Yang Y, et al
    Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-naive or Previously Treated Patients with HCV Genotype 1 or 3 Infections.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)34513.
    PubMed     Text format     Abstract available


  67. KLINGE MJ, Borhani AA, Malik SM
    Hepatitis C and Numerous Disappearing Hepatic Nodules: No-dule C It, No-dule Don't.
    Gastroenterology. 2016 May 27. pii: S0016-5085(16)30099.
    PubMed     Text format    


    April 2016
  68. WANG W, Peppelenbosch MP, Pan Q
    Targeting Viral Polymerase for Treating Hepatitis E Infection: How Far Are We?
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00362.
    PubMed     Text format    


  69. PAWLOTSKY JM
    Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens.
    Gastroenterology. 2016 Apr 11. pii: S0016-5085(16)30055.
    PubMed     Text format     Abstract available


    March 2016
  70. DI MARCO V, Calvaruso V, Ferraro D, Bavetta MG, et al
    Effects of Viral Eradication in Patients with HCV and Cirrhosis Differ With Stage of Portal Hypertension.
    Gastroenterology. 2016 Mar 31. pii: S0016-5085(16)30049.
    PubMed     Text format     Abstract available


  71. SONNEVELD MJ, Brouwer WP, van der Meer AJ
    Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B?
    Gastroenterology. 2016 Mar 25. pii: S0016-5085(16)00328.
    PubMed     Text format    


  72. AGHEMO A, Colombo M
    No Time for Bullies in Hepatitis C Virus Therapy: Genotype 3 Conquered?
    Gastroenterology. 2016 Mar 24. pii: S0016-5085(16)00378.
    PubMed     Text format    


  73. POCKROS PJ, Reddy KR, Mantry PS, Cohen E, et al
    Efficacy of Direct-acting Antiviral Combination for Patients with HCV Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.
    Gastroenterology. 2016 Mar 11. pii: S0016-5085(16)00326.
    PubMed     Text format     Abstract available


  74. THURSZ M, Morgan TR
    Treatment of Severe Alcoholic Hepatitis.
    Gastroenterology. 2016 Mar 3. pii: S0016-5085(16)00295.
    PubMed     Text format     Abstract available


    February 2016
  75. SCHATTENBERG JM, Lee MS
    Extracellular Vesicles as Messengers between Hepatocytes and Macrophages in Nonalcoholic Steatohepatitis.
    Gastroenterology. 2016 Feb 27. pii: S0016-5085(16)00255.
    PubMed     Text format    


  76. PURI P, Thursz M
    Intensive Enteral Nutrition in Alcoholic Hepatitis: More Food for Thought.
    Gastroenterology. 2016 Feb 26. pii: S0016-5085(16)00252.
    PubMed     Text format    


  77. YOUNOSSI Z, Park H, Henry L, Adeyemi A, et al
    Extra-Hepatic Manifestations of Hepatitis C-a Meta-Analysis of Prevalence, Quality of Life, and Economic Burden.
    Gastroenterology. 2016 Feb 25. pii: S0016-5085(16)00230.
    PubMed     Text format     Abstract available


  78. CRABB DW, Bataller R, Chalasani NP, Kamath PS, et al
    Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.
    Gastroenterology. 2016 Feb 24. pii: S0016-5085(16)00233.
    PubMed     Text format    


  79. SERFATY L
    Clinical implications of concomitant alcohol use, obesity and viral hepatitis.
    Gastroenterology. 2016 Feb 9. pii: S0016-5085(16)00139.
    PubMed     Text format    


  80. HASSAN T, Khan F, Kyprianou A
    A Not So Benign Abdomen!
    Gastroenterology. 2016;150:e1-2.
    PubMed     Text format    


    January 2016
  81. MORENO C, Deltenre P, Senterre C, Louvet A, et al
    Intensive Enteral Nutrition is Ineffective for Individuals with Severe Alcoholic Hepatitis Treated with Corticosteroids.
    Gastroenterology. 2016 Jan 4. pii: S0016-5085(15)01866.
    PubMed     Text format     Abstract available


  82. HIRSOVA P, Ibrahim SH, Krishnan A, Verma VK, et al
    Lipid-induced Signaling Causes Release of Inflammatory Extracellular Vesicles from Hepatocytes.
    Gastroenterology. 2016 Jan 4. pii: S0016-5085(15)01865.
    PubMed     Text format     Abstract available


  83. XUE R, Li R, Guo H, Guo L, et al
    Variable Extent of Intra-tumor Heterogeneity Revealed by Genomic Sequencing of Multiple Lesions in Patients with Hepatocellular Carcinoma.
    Gastroenterology. 2016 Jan 2. pii: S0016-5085(15)01861.
    PubMed     Text format     Abstract available


  84. XIA Y, Stadler D, Lucifora J, Reisinger F, et al
    Interferon-gamma and Tumor Necrosis Factor-alpha Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
    Gastroenterology. 2016;150:194-205.
    PubMed     Text format     Abstract available


    December 2015
  85. PARK JJ, Wong DK, Wahed AS, Lee WM, et al
    HBV-specific and global T-cell dysfunction in chronic hepatitis B.
    Gastroenterology. 2015 Dec 9. pii: S0016-5085(15)01736.
    PubMed     Text format     Abstract available


    November 2015
  86. MCMAHON BJ
    Combination of Pegylated Interferon and Tenofovir for Hepatitis B Treatment: Screening and Counseling of Patients are Warranted.
    Gastroenterology. 2015 Nov 22. pii: S0016-5085(15)01675.
    PubMed     Text format    


  87. BLOCK T, Guo JT
    The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in Site?
    Gastroenterology. 2015 Nov 22. pii: S0016-5085(15)01679.
    PubMed     Text format    


  88. RAZIORROUH B, Sacher K, Tawar RG, Emmerich F, et al
    Virus-specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-helper Cells in Patients With Acute and Chronic HCV Infections.
    Gastroenterology. 2015 Nov 13. pii: S0016-5085(15)01622.
    PubMed     Text format     Abstract available


    October 2015
  89. LAMMERT C, Comerford M, Love J, Bailey JR, et al
    Investigation Gone Viral: Application of the Social Mediasphere in Research.
    Gastroenterology. 2015;149:839-43.
    PubMed     Text format    


    September 2015
  90. KLEMANN C, Schroder A, Dreier A, Mohn N, et al
    Interleukin-17, Produced by gammadelta-T Cells, Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and is Increased in Livers of Patients.
    Gastroenterology. 2015 Sep 21. pii: S0016-5085(15)01352.
    PubMed     Text format     Abstract available


    August 2015
  91. BESTE LA, Leipertz SL, Green PK, Dominitz JA, et al
    Trends in the burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US Veterans from 2001-2013.
    Gastroenterology. 2015 Aug 5. pii: S0016-5085(15)01088.
    PubMed     Text format     Abstract available


    June 2015
  92. ZUCMAN-ROSSI J, Villanueva A, Nault JC, Llovet JM, et al
    The genetic landscape and biomarkers of hepatocellular carcinoma.
    Gastroenterology. 2015 Jun 19. pii: S0016-5085(15)00869.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: